Glenmark Pharmaceuticals reports marginal fall in Q3 consolidated net profit

12 Feb 2022 Evaluate

Glenmark Pharmaceuticals has reported results for third quarter ended December 31, 2021.

The company has reported a rise of 24% in its net profit at Rs 548.52 crore for the quarter under review as compared to Rs 442.33 crore for the same quarter in the previous year. Total income of the company increased by 9.55% at Rs 2249.80 crore for Q3FY22 as compared Rs 2053.61 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported fall of 3.40% in its net profit at Rs 239.75 crore for the quarter under review as compared to Rs 248.18 crore for the same quarter in the previous year. However, total income of the company increased by 13.75% at Rs 3187.31 crore for Q3FY22 as compared Rs 2801.85 crore for the corresponding quarter previous year.

Glenmark Pharma Share Price

1994.80 -16.70 (-0.83%)
16-Jan-2026 14:36 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1664.80
Dr. Reddys Lab 1175.50
Cipla 1393.60
Zydus Lifesciences 870.90
Lupin 2173.55
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×